FTO and acute myeloid leukemia: FTO also plays a crucial oncogenic role in AML, where it regulates expression of targets such and as ankyrin repeat retinoic acid receptor-α (RARA) and SOCS box-containing 2 (ASB2) by reducing their mRNA transcript m6A levels, thus enhancing cell transformation and leukemogenesis [181].